Drug-Induced Liver Injury
35
3
4
15
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.7%
2 terminated out of 35 trials
88.2%
+1.7% vs benchmark
9%
3 trials in Phase 3/4
13%
2 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (35)
A Real World Study of Polyene Phosphatidylcholine Injection for the Prevention and Treatment of DILI in Patients With Malignant Hematological Diseases
Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo
Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose
A Prognostic Model for Drug-induced Liver Injury in China
Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis
A Prospective Cohort Study on Drug-induced Liver Injury in China(DILI-P)
Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure
Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study
Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients
Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)
Alterations of Gut Microbiota and Serum Biochemical Markers in DILI Patients
A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects
Discrimination of DILI and AIH by Artificial Intelligence
Glucocorticosteroid Therapy on Drug-induced Liver Injury: a Prospective Non-randomized Concurrent Control Trial
Combi-elastography Assessment of Chronic Liver Disease Multi-center Study
Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs
Correlative Cohort Study on the Clinical Features and Prognosis of Drug-induced Liver Injury
A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status
A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis
Liver Enzyme Abnormalities and Risk Factors in Taking Herbal Medicine